مصطلحات الفهرس: complement factor H/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], heparin/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lipocortin 5/ec [Endogenous Compound], low molecular weight heparin/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], plasmapheresis, anticoagulant therapy, antiphospholipid syndrome/dt [Drug Therapy], antiphospholipid syndrome/et [Etiology], antiphospholipid syndrome/th [Therapy], complement activation, complement deposition, conformational transition, human, immunopathogenesis, immunosuppressive treatment, immunotherapy, priority journal, review, syncytiotrophoblast, complement component C5a/ec [Endogenous Compound], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: complement factor H/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], heparin/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lipocortin 5/ec [Endogenous Compound], low molecular weight heparin/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], plasmapheresis, anticoagulant therapy, antiphospholipid syndrome/dt [Drug Therapy], antiphospholipid syndrome/et [Etiology], antiphospholipid syndrome/th [Therapy], complement activation, complement deposition, conformational transition, human, immunopathogenesis, immunosuppressive treatment, immunotherapy, priority journal, review, syncytiotrophoblast, complement component C5a/ec [Endogenous Compound], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: low drug dose, lung embolism/dt [Drug Therapy], lung embolism/su [Surgery], lung hemorrhage/co [Complication], meta analysis (topic), morbidity, outcome assessment, postoperative care, postoperative complication/co [Complication], preoperative care, preoperative evaluation, priority journal, recurrent disease/su [Surgery], review, sternotomy, stroke patient, surgical technique, treatment contraindication, treatment failure, treatment indication, venous thromboembolism/dt [Drug Therapy], enoxaparin/dt [Drug Therapy], heparin/dt [Drug Therapy], heparin/sc [Subcutaneous Drug Administration], low molecular weight heparin/dt [Drug Therapy], low molecular weight heparin/sc [Subcutaneous Drug Administration], warfarin/dt [Drug Therapy], cardiovascular risk, acute disease/dt [Drug Therapy], acute disease/su [Surgery], anticoagulant therapy, blood clot lysis, brain hemorrhage/co [Complication], brain hemorrhage/su [Surgery], brain ischemia/co [Complication], brain ischemia/su [Surgery], cardiovascular mortality, concurrent infection/su [Surgery], critically ill patient, echocardiography, embolectomy, fibrinolysis, fibrinolytic therapy, human, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27552Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: low drug dose, mitral valve replacement, postoperative care, preoperative treatment, primary prevention, risk reduction, secondary prevention, thromboembolism/dt [Drug Therapy], thromboembolism/pc [Prevention], thrombosis prevention, venous thromboembolism/dt [Drug Therapy], fresh frozen plasma/cb [Drug Combination], fresh frozen plasma/cm [Drug Comparison], fresh frozen plasma/dt [Drug Therapy], heparin/dt [Drug Therapy], low molecular weight heparin/dt [Drug Therapy], prothrombin complex/cb [Drug Combination], prothrombin complex/cm [Drug Comparison], prothrombin complex/dt [Drug Therapy], prothrombin complex/iv [Intravenous Drug Administration], prothrombin complex/pk [Pharmacokinetics], vitamin K group/dt [Drug Therapy], vitamin K group/iv [Intravenous Drug Administration], vitamin K group/po [Oral Drug Administration], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], warfarin/iv [Intravenous Drug Administration], warfarin/po [Oral Drug Administration], risk assessment, anticoagulant therapy, aorta valve replacement, article, bleeding/dt [Drug Therapy], bleeding/si [Side Effect], blood clotting disorder/si [Side Effect], consensus development, continuous infusion, drug half life, drug indication, drug safety, emergency care, heart atrium fibrillation/dt [Drug Therapy], heart atrium fibrillation/pc [Prevention], human, international normalized ratio, invasive procedure, long term care, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42538Test
Medical Journal of Australia
Click here for full text options
LibKey Link

مصطلحات الفهرس: low drug dose, lung embolism/dt [Drug Therapy], lung embolism/su [Surgery], lung hemorrhage/co [Complication], meta analysis (topic), morbidity, outcome assessment, postoperative care, postoperative complication/co [Complication], preoperative care, preoperative evaluation, priority journal, recurrent disease/su [Surgery], review, sternotomy, stroke patient, surgical technique, treatment contraindication, treatment failure, treatment indication, venous thromboembolism/dt [Drug Therapy], enoxaparin/dt [Drug Therapy], heparin/dt [Drug Therapy], heparin/sc [Subcutaneous Drug Administration], low molecular weight heparin/dt [Drug Therapy], low molecular weight heparin/sc [Subcutaneous Drug Administration], warfarin/dt [Drug Therapy], cardiovascular risk, acute disease/dt [Drug Therapy], acute disease/su [Surgery], anticoagulant therapy, blood clot lysis, brain hemorrhage/co [Complication], brain hemorrhage/su [Surgery], brain ischemia/co [Complication], brain ischemia/su [Surgery], cardiovascular mortality, concurrent infection/su [Surgery], critically ill patient, echocardiography, embolectomy, fibrinolysis, fibrinolytic therapy, human, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27552Test
LibKey Link

مصطلحات الفهرس: low drug dose, mitral valve replacement, postoperative care, preoperative treatment, primary prevention, risk reduction, secondary prevention, thromboembolism/dt [Drug Therapy], thromboembolism/pc [Prevention], thrombosis prevention, venous thromboembolism/dt [Drug Therapy], fresh frozen plasma/cb [Drug Combination], fresh frozen plasma/cm [Drug Comparison], fresh frozen plasma/dt [Drug Therapy], heparin/dt [Drug Therapy], low molecular weight heparin/dt [Drug Therapy], prothrombin complex/cb [Drug Combination], prothrombin complex/cm [Drug Comparison], prothrombin complex/dt [Drug Therapy], prothrombin complex/iv [Intravenous Drug Administration], prothrombin complex/pk [Pharmacokinetics], vitamin K group/dt [Drug Therapy], vitamin K group/iv [Intravenous Drug Administration], vitamin K group/po [Oral Drug Administration], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], warfarin/iv [Intravenous Drug Administration], warfarin/po [Oral Drug Administration], risk assessment, anticoagulant therapy, aorta valve replacement, article, bleeding/dt [Drug Therapy], bleeding/si [Side Effect], blood clotting disorder/si [Side Effect], consensus development, continuous infusion, drug half life, drug indication, drug safety, emergency care, heart atrium fibrillation/dt [Drug Therapy], heart atrium fibrillation/pc [Prevention], human, international normalized ratio, invasive procedure, long term care, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42538Test
Medical Journal of Australia
LibKey Link

مصطلحات الفهرس: artery diameter, artery intima proliferation, article, clinical trial, controlled clinical trial, controlled study, coronary artery obstruction/dt [Drug Therapy], coronary artery obstruction/th [Therapy], coronary stent, drug eluting stent, female, follow up, heart infarction/co [Complication], human, intermethod comparison, intravascular ultrasound, left coronary artery, major clinical study, male, percutaneous coronary intervention, priority journal, randomized controlled trial, risk assessment, safety, stent, survival rate, technical aid, clopidogrel/dt [Drug Therapy], clopidogrel/pd [Pharmacology], fibrinogen receptor antagonist/dt [Drug Therapy], fibrinogen receptor antagonist/pd [Pharmacology], heparin/dt [Drug Therapy], heparin/pd [Pharmacology], low molecular weight heparin/dt [Drug Therapy], low molecular weight heparin/pd [Pharmacology], paclitaxel/ct [Clinical Trial], paclitaxel/pd [Pharmacology], rapamycin/ct [Clinical Trial], rapamycin/pd [Pharmacology], bare metal stent, cutting balloon, paclitaxel eluting stent, outcomes research, adult, aged, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31811Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], deep vein thrombosis/ep [Epidemiology], deep vein thrombosis/pc [Prevention], deep vein thrombosis/th [Therapy], delivery, diabetes mellitus, disease association, disease severity, Doppler flowmetry, dosage schedule comparison, drug substitution, drug withdrawal, embryopathy/si [Side Effect], fertilization in vitro, fetal hemorrhage/si [Side Effect], fetus outcome, fibrinolysis, high risk patient, high risk pregnancy, human, hypertension, immobilization, infection, infection complication, injection site reaction/si [Side Effect], labor, low drug dose, lung angiography, lung embolism/di [Diagnosis], lung embolism/dt [Drug Therapy], lung scintiscanning, lung ventilation perfusion ratio, maternal mortality, mother, neurologic disease/si [Side Effect], nuclear magnetic resonance imaging, obesity, obstetric patient, obstetrics, oral contraception, osteoporosis/si [Side Effect], pathophysiology, phlebography, postpartum hemorrhage/si [Side Effect], postthrombosis syndrome/pc [Prevention], preeclampsia, pregnancy, pregnant woman, priority journal, protein C deficiency, protein S deficiency, radiation exposure, recurrence risk, risk factor, skin allergy/si [Side Effect], smoking, teratogenicity/co [Complication], teratogenicity/si [Side Effect], thorax radiography, thrombocytopenia/si [Side Effect], thrombophilia, transthoracic echocardiography, twin pregnancy, ultrasound, vein blood flow, venous thromboembolism/di [Diagnosis], venous thromboembolism/dt [Drug Therapy], venous thromboembolism/ep [Epidemiology], venous thromboembolism/pc [Prevention], venous thromboembolism/th [Therapy], vertebra fracture/si [Side Effect], blood clotting factor 5 Leiden/ec [Endogenous Compound], blood clotting factor 8/ec [Endogenous Compound], brain natriuretic peptide/ec [Endogenous Compound], coumarin/ae [Adverse Drug Reaction], coumarin/dt [Drug Therapy], D dimer/ec [Endogenous Compound], dalteparin/do [Drug Dose], dalteparin/dt [Drug Therapy], dalteparin/sc [Subcutaneous Drug Administration], danaparoid/ae [Adverse Drug Reaction], danaparoid/dt [Drug Therapy], enoxaparin/do [Drug Dose], enoxaparin/dt [Drug Therapy], enoxaparin/sc [Subcutaneous Drug Administration], fondaparinux/dt [Drug Therapy], heparin/ae [Adverse Drug Reaction], heparin/do [Drug Dose], heparin/dt [Drug Therapy], heparin/iv [Intravenous Drug Administration], heparin/sc [Subcutaneous Drug Administration], heparinoid/ae [Adverse Drug Reaction], heparinoid/dt [Drug Therapy], low molecular weight heparin/ae [Adverse Drug Reaction], low molecular weight heparin/dt [Drug Therapy], low molecular weight heparin/sc [Subcutaneous Drug Administration], oral contraceptive agent, phospholipid antibody/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], plasminogen activator inhibitor 2/ec [Endogenous Compound], protein S/ec [Endogenous Compound], prothrombin/ec [Endogenous Compound], thrombin/ec [Endogenous Compound], thromboplastin/ec [Endogenous Compound], tinzaparin/do [Drug Dose], tinzaparin/dt [Drug Therapy], tinzaparin/sc [Subcutaneous Drug Administration], troponin I/ec [Endogenous Compound], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], compression leg ultrasound, maternal age, antepartum hemorrhage/si [Side Effect], anticoagulant therapy, antithrombin deficiency, article, bleeding/si [Side Effect], blood clot lysis, blood vessel injury, breast cancer/co [Complication], central nervous system disease/si [Side Effect], cesarean section, childhood cancer/co [Complication], compression garment, computed tomographic angiography, critical illness, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30327Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: elective surgery, epidural anesthesia, eye surgery, heart surgery, human, postoperative hemorrhage/co [Complication], postoperative hemorrhage/pc [Prevention], postoperative hemorrhage/su [Surgery], postoperative hemorrhage/th [Therapy], postoperative thrombosis/co [Complication], postoperative thrombosis/dt [Drug Therapy], postoperative thrombosis/pc [Prevention], risk benefit analysis, spinal anesthesia, surgical risk, unspecified side effect/si [Side Effect], venous thromboembolism/dt [Drug Therapy], venous thromboembolism/co [Complication], venous thromboembolism/pc [Prevention], acetylsalicylic acid/ae [Adverse Drug Reaction], acetylsalicylic acid/dt [Drug Therapy], anticoagulant agent/ae [Adverse Drug Reaction], anticoagulant agent/dt [Drug Therapy], anticoagulant agent/po [Oral Drug Administration], antithrombocytic agent/ae [Adverse Drug Reaction], antithrombocytic agent/dt [Drug Therapy], clopidogrel/ae [Adverse Drug Reaction], clopidogrel/dt [Drug Therapy], dabigatran/dt [Drug Therapy], dabigatran/po [Oral Drug Administration], heparin/dt [Drug Therapy], low molecular weight heparin/dt [Drug Therapy], rivaroxaban/dt [Drug Therapy], rivaroxaban/po [Oral Drug Administration], warfarin/ae [Adverse Drug Reaction], warfarin/dt [Drug Therapy], warfarin/po [Oral Drug Administration], heart atrium fibrillation/dt [Drug Therapy], artery thrombosis/dt [Drug Therapy], artery thrombosis/co [Complication], artery thrombosis/pc [Prevention], article, bleeding disorder/si [Side Effect], blood transfusion, cardiologist, consultation, coronary stent, dental surgery, dermatological procedures, drug substitution, drug withdrawal, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30342Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: lung embolism, magnetic resonance angiography, mechanical thrombectomy, pathophysiology, phlebography, portal hypertension/co [Complication], postthrombosis syndrome, recommended drug dose, review, risk factor, seizure, sepsis, surgical thrombectomy, thrombocyte count, thromboembolism/dt [Drug Therapy], thromboembolism/pc [Prevention], thrombophilia/cn [Congenital Disorder], thrombosis/di [Diagnosis], thrombosis/dm [Disease Management], thrombosis/dt [Drug Therapy], thrombosis/et [Etiology], thrombosis/pc [Prevention], thrombosis/su [Surgery], thrombosis/th [Therapy], umbilical artery catheterization, unspecified side effect/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], alteplase/cm [Drug Comparison], alteplase/dt [Drug Therapy], blood clotting factor 10/ec [Endogenous Compound], blood clotting factor 11/ec [Endogenous Compound], blood clotting factor 12/ec [Endogenous Compound], blood clotting factor 7/ec [Endogenous Compound], blood clotting factor 9/ec [Endogenous Compound], clopidogrel/ae [Adverse Drug Reaction], clopidogrel/dt [Drug Therapy], D dimer/ec [Endogenous Compound], enoxaparin/do [Drug Dose], enoxaparin/dt [Drug Therapy], heparin/do [Drug Dose], heparin/dt [Drug Therapy], low molecular weight heparin/dt [Drug Therapy], plasminogen/ec [Endogenous Compound], plasminogen activator inhibitor/ec [Endogenous Compound], prekallikrein/ec [Endogenous Compound], prothrombin/ec [Endogenous Compound], streptokinase/cm [Drug Comparison], streptokinase/dt [Drug Therapy], urokinase/cm [Drug Comparison], urokinase/dt [Drug Therapy], warfarin/dt [Drug Therapy], newborn, age distribution, anticoagulant therapy, blood clot lysis, causal attribution, central venous catheterization, clinical evaluation, congenital heart disease/cn [Congenital Disorder], critically ill patient, drug dose comparison, hemostasis, human, incidence, lethargy, long term care, low drug dose, Review

URL: Click here for full text options
LibKey Link